Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
出版年份 2015 全文链接
标题
Induced Pluripotent Stem Cell-Derived Natural Killer Cells for Treatment of Ovarian Cancer
作者
关键词
-
出版物
STEM CELLS
Volume 34, Issue 1, Pages 93-101
出版商
Wiley
发表日期
2015-10-27
DOI
10.1002/stem.2230
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Natural killer cells: The journey from puzzles in biology to treatment of cancer
- (2015) Lakshmi Narendra Bodduluru et al. CANCER LETTERS
- KIR haplotype B donors but not KIR-ligand mismatch result in a reduced incidence of relapse after haploidentical transplantation using reduced intensity conditioning and CD3/CD19-depleted grafts
- (2014) Sebastian U. Michaelis et al. ANNALS OF HEMATOLOGY
- KIR B haplotype donors confer a reduced risk for relapse after haploidentical transplantation in children with ALL
- (2014) L. Oevermann et al. BLOOD
- Past, present and future targets for immunotherapy in ovarian cancer
- (2014) Carlton L Schwab et al. Immunotherapy
- Donor Killer Cell Ig-like Receptor B Haplotypes, Recipient HLA-C1, and HLA-C Mismatch Enhance the Clinical Benefit of Unrelated Transplantation for Acute Myelogenous Leukemia
- (2014) S. Cooley et al. JOURNAL OF IMMUNOLOGY
- An Antimesothelin-Monomethyl Auristatin E Conjugate with Potent Antitumor Activity in Ovarian, Pancreatic, and Mesothelioma Models
- (2014) S. J. Scales et al. MOLECULAR CANCER THERAPEUTICS
- Natural Killer Cells for Cancer Immunotherapy: Pluripotent Stem Cells-Derived NK Cells as an Immunotherapeutic Perspective
- (2014) Cristina Eguizabal et al. Frontiers in Immunology
- Donor Haplotype B of NK KIR Receptor Reduces the Relapse Risk in HLA-Identical Sibling Hematopoietic Stem Cell Transplantation of AML Patients
- (2014) Ulla Impola et al. Frontiers in Immunology
- Intraperitoneal delivery of human natural killer cells for treatment of ovarian cancer in a mouse xenograft model
- (2013) Melissa A. Geller et al. CYTOTHERAPY
- Clinical-Scale Derivation of Natural Killer Cells From Human Pluripotent Stem Cells for Cancer Therapy
- (2013) David A. Knorr et al. Stem Cells Translational Medicine
- Mesothelin-Specific Chimeric Antigen Receptor mRNA-Engineered T Cells Induce Antitumor Activity in Solid Malignancies
- (2013) G. L. Beatty et al. Cancer Immunology Research
- Membrane-Bound IL-21 Promotes Sustained Ex Vivo Proliferation of Human Natural Killer Cells
- (2012) Cecele J. Denman et al. PLoS One
- Natural killer cells: a review of manufacturing and clinical utility
- (2012) Scott A. Koepsell et al. TRANSFUSION
- Donor selection for natural killer cell receptor genes leads to superior survival after unrelated transplantation for acute myelogenous leukemia
- (2010) S. Cooley et al. BLOOD
- A phase II study of allogeneic natural killer cell therapy to treat patients with recurrent ovarian and breast cancer
- (2010) Melissa A. Geller et al. CYTOTHERAPY
- Human Pluripotent Stem Cells Produce Natural Killer Cells That Mediate Anti-HIV-1 Activity by Utilizing Diverse Cellular Mechanisms
- (2010) Z. Ni et al. JOURNAL OF VIROLOGY
- Human embryonic stem cells differentiate into a homogeneous population of natural killer cells with potent in vivo antitumor activity
- (2009) P. S. Woll et al. BLOOD
- Control of large, established tumor xenografts with genetically retargeted human T cells containing CD28 and CD137 domains
- (2009) C. Carpenito et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- A protocol describing the use of a recombinant protein-based, animal product-free medium (APEL) for human embryonic stem cell differentiation as spin embryoid bodies
- (2008) Elizabeth S Ng et al. Nature Protocols
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started